R&D Partner Content 2nd ADC Pharmacokinetics & Clinical Pharmacology Summit Bringing together leaders in PKPD, bioanalysis, pharmacometrics, and clinical pharmacology
R&D Partner Content 6th Gene Therapy for Ophthalmic Disorders Summit | Don’t Tur... Restoring Vision through Genetic Medicine
R&D Partner Content 7th Gene Therapy for CNS Summit | An Intimate Networking Spa... Unlocking Safe & Efficacious CNS Gene Therapy
R&D Partner Content 7th Gene Therapy Analytical Development Summit | Leading AD ... Advancing Analytics & QC from Pre-IND to BLA
R&D Partner Content 2nd Innovation in Obesity Therapeutics Summit Hear from the titans of the pharmaceutical industry, including Novo Nordisk, Eli Lilly, and Boehringer Ingelheim, as well as innovative biotechs
Partner Content Partner Content Maximising the Therapeutic Potential of Complement Mediation... Capturing the Industry’s Most Exciting Developments in Complement-Based Therapeutics
News EU clears first drug therapy for rare disease cALD Neuraxpharm and Minoryx' Nezglyal has become the first approved drug therapy in the EU for rare neurodegenerative disease cALD.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.